Zelderen-Bhola, S.L. van

abnormality patient cytogenetic karyotype karyotyping chromosomal chromosome autosomal cytogenetic abnormalities monosomy strategy autosomal monosomies sample analysis chromosomal abnormalities study aml patients monosomie prognostic pregnancy american society difference group prognosis chromosomal abnormality table myeloid leukemia autosomal monosomy result leukemia mlpa strategy oncology oncology information downloaded library erasmus mc myeloid category fl uid health probe women diagnosis monosomal karyotype factor resource use outcome cost difference netherland presence american society monosomal karyotyping strategy value 4- year os non-cbf cytogenetic abnormalities amniocentesi university survival monosomy ϫ7 van putten prognostic value death department quality centre clonal cytogenetic abnormalities core binding factor berna beverloo wim l.j autosomal chromosomal monosomies clonal cost differences fl uid cells prognostic signi ficance accuracy gynecol binding decision resource obstet